Iodine-131 trips off false alarms in patient travel
Radiologists should not only take their patients' history but perhaps also record their future travel plans. Apparently, individuals undergoing diagnostic or therapeutic nuclear medicine procedures can trip radiation detectors designed to catch terrorists smuggling radioactive material.
Radiologists should not only take their patients' history but perhaps also record their future travel plans. Apparently, individuals undergoing diagnostic or therapeutic nuclear medicine procedures can trip radiation detectors designed to catch terrorists smuggling radioactive material.
One man set off an alarm in a tunnel while riding a bus from New York to Atlantic City, NJ, a few years ago. In the 1980s, two people undergoing radionuclide therapy set off detectors in the White House.
But the potential for these false alarms is rising as portable radiation monitors proliferate and the number of nuclear medicine scans increases, Dr. Lionel Zuckier said at the 2004 RSNA meeting.
Zuckier and colleagues at the University of Medicine and Dentistry of New Jersey found that iodine-131 can trigger alarms up to three months after its administration; gallium-67 and thallium-201 up to 30 days; indium-111 up to 17 days; and technetium-99m and iodine-123 up to three days.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
